Featured Research

from universities, journals, and other organizations

Gene Treatment Can Boost Heart Function In Rabbits, Duke Researchers Say

Date:
July 2, 1999
Source:
Duke University
Summary:
Scientists at Duke University Medical Center have delivered therapeutic genes throughout a rabbit's heart and have shown that the genes can both boost heart function on their own and also increase sensitivity to heart-stimulating drugs.

DURHAM, N.C. -- Scientists at Duke University Medical Center have delivered therapeutic genes throughout a rabbit's heart and have shown that the genes can both boost heart function on their own and also increase sensitivity to heart-stimulating drugs.

According to the researchers, the experiments, reported in the July 1 Journal of Clinical Investigation, are a crucial step in developing a genetic treatment for congestive heart failure. This debilitating and deadly condition develops when heart muscle loses its ability to stretch and contract, usually due to clogged arteries caused by coronary artery disease. People with congestive heart failure often experience fatigue, weakness and an inability to carry out routine daily tasks. There is currently no effective means to reverse heart failure, only to treat symptoms.

The research is funded by grants from the National Institutes of Health and the American Heart Association (AHA).

According to the AHA, about 400,000 new cases of congestive heat failure are recorded every year in the United States. Death rates from congestive heart failure tripled between 1974 and 1994, making it the leading cause of hospitalization among people 65 and older and costing more than $10 billion a year.

Research team leader Walter J. Koch, an associate professor of experimental surgery, and his colleagues have been working for several years to find ways to efficiently deliver genes to the heart to boost heart function.

In their experiments, the scientists first incorporated the therapeutic genes into a live but disabled common cold virus. Then, in a surgical technique that was a key to their success, the scientists injected the virus into the left ventricle of live rabbits while the aorta was clamped for a few seconds. This technique allowed the virus enough time to spread through all the coronary vessels to reach a majority of the heart muscle. Clamping the aorta is sometimes used in human heart surgery, Koch said, making this gene delivery method feasible.

In the current experiments, the effect of the introduced genes lasted for about three weeks. Koch said that he believes the immune system eventually clears the adenovirus from the body, eliminating the therapeutic effect. Koch emphasized that more effective methods of carrying the genes into cells need to be developed before gene therapy for heart failure in people becomes a practical option. The researchers say that with the development of improved viruses and other vehicles to introduce genes into the heart, the technique might be used on congestive heart failure patients within the next decade.

The latest achievement built on earlier basic studies in the lab of Dr. Robert Lefkowitz, a Howard Hughes Medical Institute investigator at Duke. Using mouse models and sophisticated genetic techniques, Lefkowitz and his colleagues identified the molecules responsible for fostering efficient pumping action in the heart and showed which ones can make the heart function more efficiently.

The Duke scientists showed that two key proteins in heart cells - called beta-adrenergic receptors (ARs) and beta adrenergic receptor kinase (ARK) -- work together to regulate heart function. Receptors such as AR are molecular switches that turn on cell processes when triggered by external substances such as hormones.

In reacting to a failing heart, the body releases large amounts of the hormone norepinephrine directly into the heart. This norepinephrine binds to ARs on the surface of heart cells, triggering the heart to work up to five times harder than normal. While this overstimulation initially allows the heart to increase the power of its contractions, in heart failure the stimulation quickly becomes self-defeating, because the receptors become desensitized, meaning they no longer respond to hormone stimulation.

This desensitization is caused by ARK, an enzyme inside the cell that in healthy hearts helps restore normal heart contractions after norepinephrine stimulation. In failing hearts, however, ARK levels rise and the number of ARs is greatly reduced.

In 1994, Lefkowitz, Koch and their colleagues showed that mice genetically altered to produce excess beta adrenergic receptors (ARs) have supercharged hearts that beat faster and stronger than a normal mouse's heart. In 1997, the researchers inserted a gene that encodes the AR into an adenovirus.

"Our studies have shown that a malfunctioning beta adrenergic receptor system greatly contributes to heart failure," Koch said. "By contrast, boosting levels of beta adrenergic receptors or inhibiting ARK can reverse heart failure in genetic mouse models. Now, we are beginning to see the same result when we deliver these genes to rabbits."

In their earlier test tube experiments Koch and his colleagues allowed the virus to infect isolated failing rabbit heart cells. They found that the inserted AR genes produced up to 15 times the normal amount of the AR protein found in rabbit cells, which restored normal heart signaling.In the current experiments, the animals' heart cells produced the equivalent of 10 times the normal number of ARs. As a result, they shows a 20 percent increase in the force of their heart contractions.

In addition, the researchers tested the effects of a range of concentrations of ARs and found that as they increased AR, they increased the force of contraction to a maximum of 20 percent.

The researchers tested whether the ARs would respond to the drug isoproteronol, which stimulates ARs. When researchers injected the drug into both normal rabbits and rabbits with the additional ARs, they found the rabbit hearts with the additional ARs responded to the drug even more so than the normal rabbits.

"Our results with the isoproterenol challenge show that the ARs we have inserted into the heart are functioning and responding just like the native AR," said Koch.

Heart surgeon Donald Glower, and researchers John Maurice, Jonathan Hata, Ashish Shah, David White, Patricia McDonald, Paul Dolber and Katrina Wilson also contributed to the study.


Story Source:

The above story is based on materials provided by Duke University. Note: Materials may be edited for content and length.


Cite This Page:

Duke University. "Gene Treatment Can Boost Heart Function In Rabbits, Duke Researchers Say." ScienceDaily. ScienceDaily, 2 July 1999. <www.sciencedaily.com/releases/1999/07/990702080321.htm>.
Duke University. (1999, July 2). Gene Treatment Can Boost Heart Function In Rabbits, Duke Researchers Say. ScienceDaily. Retrieved October 2, 2014 from www.sciencedaily.com/releases/1999/07/990702080321.htm
Duke University. "Gene Treatment Can Boost Heart Function In Rabbits, Duke Researchers Say." ScienceDaily. www.sciencedaily.com/releases/1999/07/990702080321.htm (accessed October 2, 2014).

Share This



More Health & Medicine News

Thursday, October 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pregnancy Spacing Could Have Big Impact On Autism Risks

Pregnancy Spacing Could Have Big Impact On Autism Risks

Newsy (Oct. 1, 2014) A new study says children born less than one year and more than five years after a sibling can have an increased risk for autism. Video provided by Newsy
Powered by NewsLook.com
Robotic Hair Restoration

Robotic Hair Restoration

Ivanhoe (Oct. 1, 2014) A new robotic procedure is changing the way we transplant hair. The ARTAS robot leaves no linear scarring and provides more natural results. Video provided by Ivanhoe
Powered by NewsLook.com
Insertable Cardiac Monitor

Insertable Cardiac Monitor

Ivanhoe (Oct. 1, 2014) A heart monitor the size of a paperclip that can save your life. The “Reveal Linq” allows a doctor to monitor patients with A-Fib on a continuous basis for up to 3 years! Video provided by Ivanhoe
Powered by NewsLook.com
Attacking Superbugs

Attacking Superbugs

Ivanhoe (Oct. 1, 2014) Two weapons hospitals can use to attack superbugs. Scientists in Ireland created a new gel resistant to superbugs, and a robot that can disinfect a room in minutes. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins